Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin

Ambrosioni Czyrko, Juan; Mamin, Aline; Hadengue, A; Bernimoulin, M; Samii, Kaveh; Landelle, Caroline; Negro, F; Kaiser, Laurent

doi:10.1111/1469-0691.12576

Scientific article

English

Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin

ContributorsAmbrosioni Czyrko, Juan; Mamin, Aline; Hadengue, A; Bernimoulin, M; Samii, Kaveh; Landelle, Caroline; Negro, F; Kaiser, Laurent

Published inClinical microbiology and infection, vol. 20, no. 10, p. O718-O720

Publication date2014

Abstract

Hepatitis E virus (HEV) can cause chronic infections in immunocompromised hosts. Viral kinetics in plasma and stools are poorly understood, particularly during antiviral treatment. Prolonged faecal shedding may be a concern for transmission. We describe HEV kinetics in an immunocompromised patient with prolonged faecal shedding despite undetectable viraemia on ribavirin treatment.

Affiliation

Faculté de médecine / Section de médecine clinique / Département de médecine

Research group

Groupe Laurent Kaiser (virologie clinique) (668)

Citation (ISO format)

AMBROSIONI CZYRKO, Juan et al. Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin. In: Clinical microbiology and infection, 2014, vol. 20, n° 10, p. O718–O720. doi: 10.1111/1469-0691.12576

Article (Published version)

Identifiers

PID : unige:38356
DOI : 10.1111/1469-0691.12576
PMID : 24476456

ISSN of the journal1198-743X

571views

1downloads

Creation04/17/2014 9:19:00 AM

First validation04/17/2014 9:19:00 AM

Update time03/14/2023 9:24:52 PM

Status update03/14/2023 9:24:51 PM

Last indexation01/16/2024 11:13:44 AM

Archive ouverte UNIGE

Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin

Technical informations